(Q37461052)

20 August 2017

title

Schizophrenia: from the brain to peripheral markers. A consensus paper of the WFSBP task force on biological markers (English)

1 reference

20 August 2017

0 references

7

Birte Y Glenthoj

1 reference

20 August 2017

Andrea Schmitt

17

0 references

Peter Falkai

object named as

Peter Falkai

4

0 references

Johannes Kornhuber

object named as

Johannes Kornhuber

11

0 references

Michal Schwartz

18

object named as

Michal Schwartz

1 reference

20 August 2017

13

Norbert Muller

1 reference

20 August 2017

19

Johannes Thome

1 reference

20 August 2017

22

Peter Riederer

1 reference

20 August 2017

2

Dorit Ben-Shachar

1 reference

20 August 2017

20

Marat Uzbekov

1 reference

20 August 2017

Gerald Stober

1

1 reference

20 August 2017

M Cardon

3

1 reference

20 August 2017

Alfred N Fonteh

5

1 reference

20 August 2017

Micha Gawlik

6

1 reference

20 August 2017

Edna Grunblatt

8

1 reference

20 August 2017

Assen Jablensky

9

1 reference

20 August 2017

Yong-Ku Kim

10

1 reference

20 August 2017

Thomas F McNeil

12

1 reference

20 August 2017

Bob Oranje

14

1 reference

20 August 2017

Toshikazu Saito

15

1 reference

20 August 2017

Mohamed Saoud

16

1 reference

20 August 2017

Nuria Durany

21

1 reference

20 August 2017

language of work or name

1 reference

1 January 2009

1 reference

World Journal of Biological Psychiatry

20 August 2017

published in

1 reference

20 August 2017

volume

10

1 reference

20 August 2017

issue

2

1 reference

20 August 2017

page(s)

127-155

1 reference

Do we still believe in the dopamine hypothesis? New data bring new evidence

20 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F15622970902898980

Alterations of benzodiazepine receptors in type II alcoholic subjects measured with SPECT and [123I]iomazenil

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970902898980

Increased baseline occupancy of D2 receptors by dopamine in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970902898980

Molecular and cellular mechanisms of altered GAD1/GAD67 expression in schizophrenia and related disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970902898980

Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the SzGene database

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970902898980

Schizophrenia and affective disorders--cosegregation with a translocation at chromosome 1q42 that directly disrupts brain-expressed genes: clinical and P300 findings in a family.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970902898980

Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970902898980

Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970902898980

Serologic evidence of prenatal influenza in the etiology of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970902898980

Complexity of prefrontal cortical dysfunction in schizophrenia: more than up or down

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970902898980

The current status of the dopamine hypothesis of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970902898980

3,4-Dihydroxyphenylalanine and 5-hydroxytryptophan as reserpine antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970902898980

Comparative effects of oxygen on indoleamine 2,3-dioxygenase and tryptophan 2,3-dioxygenase of the kynurenine pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970902898980

Presynaptic dopaminergic function in the striatum of schizophrenic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970902898980

White matter changes in schizophrenia: evidence for myelin-related dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970902898980

The concept of progressive brain change in schizophrenia: implications for understanding schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970902898980

Convergent evidence for impaired AKT1-GSK3beta signaling in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970902898980

The antisaccade: a review of basic research and clinical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970902898980

Identification of disease markers in human cerebrospinal fluid using lipidomic and proteomic methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970902898980

Lymphocytes as a neural probe: potential for studying psychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970902898980

The Yin and Yang of dopamine release: a new perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970902898980

The Consortium on the Genetics of Schizophrenia: neurocognitive endophenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970902898980

Genetic evidence for a distinct subtype of schizophrenia characterized by pervasive cognitive deficit

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970902898980

Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970902898980

Posttraumatic therapeutic vaccination with modified myelin self-antigen prevents complete paralysis while avoiding autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970902898980

D-serine efficacy as add-on pharmacotherapy to risperidone and olanzapine for treatment-refractory schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970902898980

Reelin, lipoprotein receptors and synaptic plasticity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970902898980

Depressive symptoms and presynaptic dopamine function in neuroleptic-naive schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970902898980

Presynaptic dopamine function in striatum of neuroleptic-naive schizophrenic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970902898980

Verbal working memory impairments in individuals with schizophrenia and their first-degree relatives: findings from the Consortium on the Genetics of Schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970902898980

Dopamine transporter change in drug-naı̈ve schizophrenia: an imaging study with 99mTc-TRODAT-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970902898980

What happens after the first episode? A review of progressive brain changes in chronically ill patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970902898980

Dopamine: 50 years in perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970902898980

Subtyping schizophrenia: implications for genetic research

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970902898980

T cell deficiency leads to cognitive dysfunction: implications for therapeutic vaccination for schizophrenia and other psychiatric conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970902898980

Molecular abnormalities in the major psychiatric illnesses: Classification and Regression Tree (CRT) analysis of post-mortem prefrontal markers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970902898980

NMDA receptors and schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970902898980

Schizophrenia proteomics: biomarkers on the path to laboratory medicine?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970902898980

Dopamine and serotonin transporters in patients with schizophrenia: an imaging study with [(123)I]beta-CIT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970902898980

Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970902898980

Asymmetrical reductions of hippocampal NMDAR1 glutamate receptor mRNA in the psychoses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970902898980

Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: Schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970902898980

Antipsychotic drug effects on brain morphology in first-episode psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970902898980

A protein-protein interaction network for human inherited ataxias and disorders of Purkinje cell degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970902898980

Increased dopamine synthesis rate in medial prefrontal cortex and striatum in schizophrenia indicated by L-(beta-11C) DOPA and PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970902898980

Prefrontal cortex dysfunction during working memory performance in schizophrenia: reconciling discrepant findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970902898980

Presynaptic dopaminergic dysfunction in schizophrenia: a positron emission tomographic [18F]fluorodopa study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970902898980

Adult schizophrenia following prenatal exposure to an influenza epidemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970902898980

Reduced prefrontal activity predicts exaggerated striatal dopaminergic function in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970902898980

Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970902898980

Identification of loci associated with schizophrenia by genome-wide association and follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970902898980

Neuropsychology and neuropharmacology of P3a and P3b.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970902898980

Elevated dopa decarboxylase activity in living brain of patients with psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970902898980

T-helper-1 and T-helper-2 responses in psychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970902898980

The principal features and mechanisms of dopamine modulation in the prefrontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970902898980

Regional specificity in the neuropathologic substrates of schizophrenia: a morphometric analysis of Broca's area 44 and area 9.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970902898980

Cognitive deficits in relatives of patients with schizophrenia: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970902898980

Cognitive deficits in unaffected first-degree relatives of schizophrenia patients: a meta-analytic review of putative endophenotypes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970902898980

Large recurrent microdeletions associated with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970902898980

Neuregulin 1 and susceptibility to schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970902898980

Splitting schizophrenia: periodic catatonia-susceptibility locus on chromosome 15q15

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970902898980

Specific inhibition of cyclooxygenase 2 restores antitumor reactivity by altering the balance of IL-10 and IL-12 synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970902898980

Genetic variation in the 6p22.3 gene DTNBP1, the human ortholog of the mouse dysbindin gene, is associated with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970902898980

Oligodendrocyte dysfunction in schizophrenia and bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970902898980

Dopamine hypothesis of schizophrenia: making sense of it all.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970902898980

Epigenetic mechanisms expressed in basal ganglia GABAergic neurons differentiate schizophrenia from bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970902898980

The emerging field of lipidomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970902898980

Meta-analysis of regional brain volumes in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970902898980

Strong association of de novo copy number mutations with sporadic schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970902898980

Immune cells contribute to the maintenance of neurogenesis and spatial learning abilities in adulthood

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970902898980

Search for cognitive trait components of schizophrenia reveals a locus for verbal learning and memory on 4q and for visual working memory on 2q.

21 January 2018

1 reference

COCI

https://opencitations.net/index/coci/api/v1/citations/10.1093/HMG/DDH184

10.1080/15622970902898980

30 October 2021

Identifiers

DOI

1 reference

20 August 2017

1 reference